Furthermore, the overexpression of GPX6 elevated dopamine‐ and cAMP‐regulated phosphoprotein, Mr 32 kDa (DARPP‐32) expression in the R6/2 model, a molecular marker of HD progression. Here, GPX6 is linked to Huntington disease.